Clinical Trials Sponsored by Julius Center

Total 84611 results

Jonsson Comprehensive Cancer Center

Withdrawn

Targeted Biopsies in Determining Response in Patients With Prostate Cancer Undergoing High-Dose-Rate Brachytherapy

Stage III Prostate Adenocarcinoma

United States
Case Comprehensive Cancer Center

Completed

Lifestyle Change and Quality of Life in Obese Patients With Stage I/II Endometrial Cancer in Remission

Endometrial Cancer | Weight Changes

United States
Vanderbilt-Ingram Cancer Center

Terminated

Yoga Intervention in Supporting Children With Cancer and Their Parents During Chemotherapy Infusion

Malignant Neoplasm

United States
Case Comprehensive Cancer Center

Completed

Treating Patients With Prostate Cancer That Did Not Respond to Hormone Therapy

Prostate Cancer

United States
Case Comprehensive Cancer Center

Withdrawn

Bupivacaine Versus Liposomal Bupivacaine For Breast Pain Management After Breast Recontruction

Breast Cancer
National Cancer Center, Korea

Enrolling by invitation

Prospective Cohort Study of Pancreatic Cancer Patients Treated With Proton Beam Therapy

Pancreas Cancer

Korea, Republic of
M.D. Anderson Cancer Center

Completed

Primary Breast Cancer Occurring Concomitant With Pregnancy

Breast Cancer | Pregnancy

United States
Case Comprehensive Cancer Center

Withdrawn

Rapid First Contact Using Virtual Visits to Improve Time-To-Treatment for Uterine Cancer

Uterine Cancer
M.D. Anderson Cancer Center

Completed

Study of Vemurafenib, Carboplatin, and Paclitaxel

Advanced Cancers

United States
M.D. Anderson Cancer Center

Completed

Simultaneous Integrated Boost (SIB) in Esophageal Cancer

Esophageal Cancer

United States
M.D. Anderson Cancer Center

Completed

Decitabine for Older or Unfit Patients With Acute Myeloid Leukemia (AML)

Leukemia

United States
Case Comprehensive Cancer Center

Completed

End Nicotine Dependence Clinic

Smoking Cessation

United States
M.D. Anderson Cancer Center

Completed

SRS Study in Patients With Non-Small Cell Lung Cancer

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Standard Dose Bevacizumab Versus Low Dose Bevacizumab Plus Lomustine (CCNU) for Recurrent Glioblastoma Multiforme (GBM)

Glioblastoma | Brain Cancer

United States
Fox Chase Cancer Center

Terminated

Development of Real-time Image-guided Radiotherapy

Breast Cancer | Lung Cancer | Skin Cancer

United States
M.D. Anderson Cancer Center

Completed

A Study of Different Doses of Ibrutinib in Participants With Chronic Lymphocytic Leukemia (CLL)

Chronic Lymphocytic Leukemia

United States
M.D. Anderson Cancer Center

Completed

Clofarabine, Idarubicin, and Cytarabine (CIA) Versus Fludarabine, Idarubicin, and Cytarabine (FLAI) in Acute Myelogenous Leukemia (AML) and High-Risk Myelodysplastic Syndrome

Leukemia

United States
Case Comprehensive Cancer Center

Completed

Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

REcovery of Left Ventricular Dysfunction in CAncer Patients (RECAP Trial)

Heart Failure | Cancer Treatment Induced Left Ventricular Dysfunction

United States
M.D. Anderson Cancer Center

Terminated

Vincristine, Doxorubicin, Cyclophosphamide and Dexrazoxane (VACdxr) in High Risk Ewing's Sarcoma Patients

Ewing's Sarcoma

United States
M.D. Anderson Cancer Center

Unknown

Understanding Patient's Knowledge and Use of Acetaminophen

Liver Failure

United States
M.D. Anderson Cancer Center

Completed

Aza-SAHA-GBM With AutoSCT for Refractory Lymphoma

Lymphoma | Advanced Cancers

United States
M.D. Anderson Cancer Center

Withdrawn

Infusion of Allogeneic, 3rd Party CD19-specific T Cells

Lymphoma | Leukemia | Blood And Marrow Transplantation
M.D. Anderson Cancer Center

Unknown

Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism

Primary Hyperparathyroidism

United States
M.D. Anderson Cancer Center

Terminated

Metformin in Non Small Cell Lung Cancer (NSCLC)

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

High-Dose Gemcitabine, Busulfan and Melphalan for Patients With Refactory Hodgkin's Disease

Lymphoma

United States
M.D. Anderson Cancer Center

Terminated

Brentuximab Vedotin in High-Risk CD30+ Lymphoma Post Allogeneic Stem Cell Transplantation (AlloSCT)

Lymphoma

United States
National Cancer Center, Korea

Completed

ICG-coated Endoscopic Clip for Tumor Localization

Colorectal Neoplasms

Korea, Republic of
Case Comprehensive Cancer Center

Completed

Using Decision Analysis to Enhance Decision-Making Regarding Prostate Cancer Screening

Prostate Cancer

United States
M.D. Anderson Cancer Center

Completed

Melanoma Vaccine With Peptides and Leuprolide

Melanoma

United States
M.D. Anderson Cancer Center

Unknown

Cancer Patients Diagnosed With Unsuspected Venous Thromboembolism (VTE) on Routine Computed Tomography (CT) Scans

Cancer | Venous Thromboembolism

United States
Case Comprehensive Cancer Center

Completed

Temsirolimus and Bevacizumab in Hormone-Resistant Metastatic Prostate Cancer That Did Not Respond to Chemotherapy

Prostate Cancer

United States
Case Comprehensive Cancer Center

Withdrawn

A Study of the Use of AirXpanders AeroForm in Patients Undergoing Post-Mastectomy Radiation Therapy

Breast Cancer
M.D. Anderson Cancer Center

Completed

Mesenchymal Stem Cells (MSC) for Ovarian Cancer

Ovarian Cancer

United States
M.D. Anderson Cancer Center

Unknown

Telephone Counseling-Mailed Materials Versus Internet Interventions in Overweight Cancer Survivors

Breast Cancer | Colorectal Cancer | Prostate Cancer

United States
M.D. Anderson Cancer Center

Unknown

Six-Minute Walk Test in Patients at High Risk for Complications From Lung Resection

Lung Cancer

United States
M.D. Anderson Cancer Center

Unknown

Data Collection of Normal Tissue Toxicity for Proton Therapy for Pediatrics

Pediatric Cancer

United States
Case Comprehensive Cancer Center

Completed

Anti-Platelet and Statin Therapy to Prevent Cancer-Associated Thrombosis

Cancer | Solid Tumor

United States
M.D. Anderson Cancer Center

Terminated

Tissue Pharmacokinetics of Intraoperative Gemcitabine in Resectable Adenocarcinoma of the Pancreas

Pancreatic Cancer

United States
M.D. Anderson Cancer Center

Completed

Bioprosthetic Mesh to Expand the Lower Pole in Tissue Expander Reconstruction

Breast Cancer

United States
M.D. Anderson Cancer Center

Completed

Effectiveness of Bronchoscopic Interventions for Malignant Airway Obstruction

Lung Cancer

United States
M.D. Anderson Cancer Center

Completed

Doxil, Bevacizumab and Temsirolimus Trial

Advanced Cancer

United States
Case Comprehensive Cancer Center

Completed

Path2Quit Tobacco Intervention For African Americans

Smoking Cessation | Smoking, Tobacco

United States
M.D. Anderson Cancer Center

Completed

Robotic Harvest of the Latissimus Dorsi (LD) Muscles

Cancer | Complications | Surgical Procedure, Unspecified | Other Reconstructive Surgery | Failure of Muscle Graft

United States
M.D. Anderson Cancer Center

Completed

Message 2: The Effect of Message Content and Clinical Outcome on Patient's Perception of Physician Compassion

Advanced Cancers

United States
Case Comprehensive Cancer Center

Completed

Dacarbazine and Recombinant Interferon Alfa-2b in Treating Patients With Primary Uveal Melanoma With Genetic Imbalance

Ciliary Body and Choroid Melanoma, Medium/Large Size | Ciliary Body and Choroid Melanoma, Small Size | Iris Melanoma | Recurrent Intraocular Melanoma

United States
Fox Chase Cancer Center

Terminated

Impact of Ribociclib on Head and Neck Squamous Cell Cancer

Squamous Cell Carcinoma of the Head and Neck

United States
Case Comprehensive Cancer Center

Completed

Building Caregiver Skills Using a Simulation-based Intervention for Care of Head and Neck Cancer

Head and Neck Cancer

United States
M.D. Anderson Cancer Center

Terminated

Data Collection of Demographics and Perioperative Care of Patients Undergoing Laparoscopic Surgery

Laparoscopy

United States
M.D. Anderson Cancer Center

Terminated

A First-in-Man, Phase I Evaluation of A Single Cycle of Prohibitin Targeting Peptide 1 in Patients With Metastatic Prostate Cancer and Obesity

Prostate Cancer

United States

Clinical Trials Sponsored by Julius Center

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in United Arab Emirates

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations